Timothy A. Springer - Sep 25, 2024 Form 4 Insider Report for Cartesian Therapeutics, Inc. (RNAC)

Signature
/s/ Matthew Bartholomae, Attorney-in-Fact for Timothy A. Springer
Stock symbol
RNAC
Transactions as of
Sep 25, 2024
Transactions value $
$0
Form type
4
Date filed
9/27/2024, 04:13 PM
Previous filing
Sep 26, 2024
Next filing
Oct 4, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RNAC Series B Non-Voting Convertible Preferred Stock Options Exercise -1.64M -100% 0 Sep 25, 2024 Direct F1
transaction RNAC Common Stock Options Exercise +1.64M +37.37% 6.02M Sep 25, 2024 Direct F1
transaction RNAC Series B Non-Voting Convertible Preferred Stock Options Exercise -721K -100% 0 Sep 25, 2024 See Footnote F1, F2
transaction RNAC Common Stock Options Exercise +721K +37.42% 2.65M Sep 25, 2024 See Footnote F1, F2
transaction RNAC Series B Non-Voting Convertible Preferred Stock Options Exercise -1.31K -100% 0 Sep 25, 2024 By wife F1
transaction RNAC Common Stock Options Exercise +1.31K +11.36% 12.8K Sep 25, 2024 By wife F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On September 20, 2024, the issuer held a special meeting of stockholders (the "Special Meeting"). At the Special Meeting, the stockholders of the issuer approved the conversion of the issuer's Series B Non-Voting Convertible Preferred Stock ("Series B Preferred Stock") into shares of common stock. On September 25, 2024, the conversion of the majority of the shares of Series B Preferred Stock occurred automatically (the "Automatic Conversion"). The remaining shares of Series B Preferred Stock remain subject to certain beneficial ownership limitations described in the issuer's filings with the Securities and Exchange Commission. At the time of the Automatic Conversion, all of the shares of Series B Preferred Stock beneficially owned by the reporting person converted into shares of common stock.
F2 Held by TAS Partners LLC. The reporting person is the managing member of TAS Partners LLC. The reporting person disclaims beneficial ownership of the securities held by TAS Partners LLC except to the extent of his pecuniary interest therein, if any.